PHM
48
-2
WMT
67
-3
UNM
67
-3
IBM
53
-2
MCK
56
-3
CL
47
-3
INTU
54
-3
FITB
33
-3
LRCX
58
-3
DE
48
-2
ICE
55
-2
PDCO
75
-2
YUM
42
-3
WYNN
34
-2
ABBV
48
-2
MS
69
-3
XRX
55
-2
EXR
30
-3
GE
62
-2
TDC
67
-3
PHM
48
-2
WMT
67
-3
UNM
67
-3
IBM
53
-2
MCK
56
-3
CL
47
-3
INTU
54
-3
FITB
33
-3
LRCX
58
-3
DE
48
-2
ICE
55
-2
PDCO
75
-2
YUM
42
-3
WYNN
34
-2
ABBV
48
-2
MS
69
-3
XRX
55
-2
EXR
30
-3
GE
62
-2
TDC
67
-3
Financhill
Back

NewAmsterdam Pharma Co NV Stock Predictions

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
43

NAMS
NewAmsterdam Pharma Co NV

Last Price:
$25.92
Seasonality Move:
41.96%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

NewAmsterdam Pharma Co NV Stock Forecast

  • Over the next 52 weeks, NewAmsterdam Pharma Co NV has on average historically risen by 48.7% based on the past 3 years of stock performance.
  • NewAmsterdam Pharma Co NV has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is NewAmsterdam Pharma Co NV Stock Undervalued?
    The current NewAmsterdam Pharma Co NV [NAMS] share price is $25.86. The Score for NAMS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • NAMS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will NewAmsterdam Pharma Co NV Stock Go Up Next Year?

  • Over the next 52 weeks, NewAmsterdam Pharma Co NV has on average historically risen by 48.7% based on the past 3 years of stock performance.

NewAmsterdam Pharma Co NV Stock Rating

Sell
43
NewAmsterdam Pharma Co NV (NAMS) is a Sell

Is NewAmsterdam Pharma Co NV overpriced?

  • NewAmsterdam Pharma Co NV has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

NewAmsterdam Pharma Co NV Stock Price History

Is NAMS stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NAMS is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Netherlands
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
newamsterdampharma.com

52-Week Data

52-Week High:
27.29
52-Week Low:
11.03

Prediction Charts

Market Cap:
2.4B
Price in USD:
25.86
Volume:
459.5K
Beta:
0.06

Technical Analysis

SMA50:
21.83
SMA100:
19.23
SMA200:
19.65
52-Wk Change:
130.89%

Stock Predictions

  • Is NewAmsterdam Pharma Co NV stock public?
    Yes, NewAmsterdam Pharma Co NV is a publicly traded company.
  • What is the NewAmsterdam Pharma Co NV stock quote today?
    The NewAmsterdam Pharma Co NV stock price is 25.86 USD today.
  • How to buy NewAmsterdam Pharma Co NV stock online?
    You can buy NewAmsterdam Pharma Co NV shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-9 18.37 18.52 19.07 17.81
Dec-10 25.00 26.19 26.36 22.23
Dec-11 26.90 25.57 27.29 24.46
Dec-12 24.43 25.09 26.58 24.43
Dec-13 24.99 24.69 25.17 24.38
Dec-16 24.75 24.71 25.00 24.46
Dec-17 24.50 26.61 26.89 24.40
Dec-18 26.00 25.89 26.95 25.00
Dec-19 25.36 25.46 26.00 24.76
Dec-20 24.86 25.50 26.25 24.55
Dec-23 25.67 25.63 25.90 24.85
Dec-24 25.61 25.95 26.00 25.23
Dec-26 25.83 26.23 26.25 25.71
Dec-27 26.25 25.86 26.33 25.71

NewAmsterdam Pharma Co NV Earnings

NewAmsterdam Pharma Co NV Earnings Report: Per Share NewAmsterdam Pharma Co NV Earnings Q1 Q2 Q3 and Q4 last year and next year.

NewAmsterdam Pharma Co NV Forecast Revenue Growth

NewAmsterdam Pharma Co NV Stock Analysis: Historical quarterly revenues per share for NewAmsterdam Pharma Co NV and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.26 per share.

* NewAmsterdam Pharma Co NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.